PharmaGraphX

Log in Get Started

Filgrastim

Granix, Zarxio, Nivestym, Neupogen, Releuko, Nypozi

Biologic agent

Standard

Half-life

3.5 hours

Protein Binding

N/A

Metabolized By

N/A

External

Drugs.com

Mechanism of action

Recombinant G-CSF; stimulates neutrophil production, maturation, and activation

Recorded indications

From the drug index — may include conditions studied rather than approved indications

·Acute Myeloid Leukemia Post Cytotoxic Therapy
·Recurrent Acute Myeloid Leukemia
·Refractory Acute Myeloid Leukemia
·DOCK8 Deficiency
·Acute Lymphoblastic Leukemia

Interactions

No curated interaction pairs are recorded for Filgrastim. This is not a statement that none exist — check a full interaction reference before combining.

Common adverse effects

Bone pain
Injection site reactions
Splenomegaly

Pharmacokinetics

Half-life: 3.5 hours
Protein binding: N/A

Pregnancy & lactation

Not recorded for Filgrastim. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.

Sources

Assembled from: drug index, curated drug database.

Not a substitute for clinical judgement